Historique
Bulletin de Périodique
Drug Testing and Analysis , Vol.9, n°7-8 - July-August 2017
Paru le :
01/08/2017
Année
2017
Page(s) :
961-1274
Langue(s) :
Anglais
Discipline :
PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods)
Note de contenu :
SELECTION :
- Detection of the designer benzodiazepine metizolam in urine and preliminary data on its metabolism. Kintz P., Richeval C., Jamey C., Ameline A., Allorge D., Gaulier J.-M., et al., p. 1026-1033.
- Assessing cannabis consumption frequency: Is the combined use of free and glucuronidated THCCOOH blood levels of diagnostic utility? Hädener M., Martin Fabritius M., König S., Giroud C., Weinmann W., p. 1043-1051.
- Targeted and non-targeted drug screening in whole blood by UHPLC-TOF-MS with data-independent acquisition. Mollerup C.B., Dalsgaard P.W., Mardal M., Linnet K., p. 1052-1061.
- Identification and characterization of a putative new psychoactive substance, 2-(2-(4-chlorophenyl)acetamido)-3-methylbutanamide, in Spain. Fabregat-Safont D., Fornís I., Ventura M., Gil C., Calzada N., Sancho J.V., et al., p. 1073-1080.
- Identification and analytical characterization of nine synthetic cathinone derivatives N-ethylhexedrone, 4-Cl-pentedrone, 4-Cl-alpha-EAPP, propylone, N-ethylnorpentylone, 6-MeO-bk-MDMA, alpha-PiHP, 4-Cl-alpha-PHP, and 4-F-alpha-PHP. Liu C., Jia W., Li T., Hua Z., Qian Z., p. 1162-1171.
- A sensitive assay for urinary cocaine metabolite benzoylecgonine shows more positive results and longer half-lives than those using traditional cut-offs. Nickley J., Pesce A.J., Krock K., p. 1214-1216.
- Identification and analytical characterization of six synthetic cannabinoids NNL-3, 5F-NPB-22-7N, 5F-AKB-48-7N, 5F-EDMB-PINACA, EMB-FUBINACA, and EG-018. Liu C., Jia W., Hua Z., Qian Z., p. 1251-1261.
- Alpha-PVP as an active component of herbal highs in Poland between 2013 and 2015. Byrska B., Stanaszek R., Zuba D., p. 1267-1274.
- Detection of the designer benzodiazepine metizolam in urine and preliminary data on its metabolism. Kintz P., Richeval C., Jamey C., Ameline A., Allorge D., Gaulier J.-M., et al., p. 1026-1033.
- Assessing cannabis consumption frequency: Is the combined use of free and glucuronidated THCCOOH blood levels of diagnostic utility? Hädener M., Martin Fabritius M., König S., Giroud C., Weinmann W., p. 1043-1051.
- Targeted and non-targeted drug screening in whole blood by UHPLC-TOF-MS with data-independent acquisition. Mollerup C.B., Dalsgaard P.W., Mardal M., Linnet K., p. 1052-1061.
- Identification and characterization of a putative new psychoactive substance, 2-(2-(4-chlorophenyl)acetamido)-3-methylbutanamide, in Spain. Fabregat-Safont D., Fornís I., Ventura M., Gil C., Calzada N., Sancho J.V., et al., p. 1073-1080.
- Identification and analytical characterization of nine synthetic cathinone derivatives N-ethylhexedrone, 4-Cl-pentedrone, 4-Cl-alpha-EAPP, propylone, N-ethylnorpentylone, 6-MeO-bk-MDMA, alpha-PiHP, 4-Cl-alpha-PHP, and 4-F-alpha-PHP. Liu C., Jia W., Li T., Hua Z., Qian Z., p. 1162-1171.
- A sensitive assay for urinary cocaine metabolite benzoylecgonine shows more positive results and longer half-lives than those using traditional cut-offs. Nickley J., Pesce A.J., Krock K., p. 1214-1216.
- Identification and analytical characterization of six synthetic cannabinoids NNL-3, 5F-NPB-22-7N, 5F-AKB-48-7N, 5F-EDMB-PINACA, EMB-FUBINACA, and EG-018. Liu C., Jia W., Hua Z., Qian Z., p. 1251-1261.
- Alpha-PVP as an active component of herbal highs in Poland between 2013 and 2015. Byrska B., Stanaszek R., Zuba D., p. 1267-1274.
Autre(s) lien(s) :
http://onlinelibrary.wiley.com/doi/10.1002/dta.v9.7/issuetoc ; http://onlinelibrary.wiley.com/doi/10.1002/dta.v9.8/issuetoc
Cote :
Abonnement